The Levitronix CentriMag ventricular assist device as a bridge to decision in patients with end-stage heart failure: Our single-center experience
No Thumbnail Available
Date
2017
Journal Title
Journal ISSN
Volume Title
Publisher
Baycinar Medical Publ-baycinar Tibbi Yayincilik
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Background: In this study, we report early outcomes of Levitronix CentriMag device implantation for bridge to decision for patients with end-stage heart failure in a single center. Methods: We retrospectively analyzed data of a total of 41 patients (30 males, 11 females: mean age 30.2 +/- 15 years; range 7 to 59 years) with end-stage heart failure who received a Levitronix CentriMag support for bridge to decision between December 2010 and September 2014. Devices were implanted in the left (n=38), right (n=1), or biventricular (n=2) configuration. Support was continued until recovery, transplantation or implantation of a long-term ventricular assist device. Results: The mean preoperative left ventricular ejection fraction was 17 +/- 2.3%. The mean support time was 38 (range 1 to 192) days. Sixteen patients (39%) survived and moved on to the next phase of the treatment. Of these patients, 11 (27%) underwent cardiac transplantation operations and five (12%) received long-term ventricular assist devices. After the CentriMag implantation, 30-day survival rate was 49% in 20 patients. Bleeding requiring re-operation was observed in 13 patients (32%). Two patients (4.8%) had sternal wound infections. Device dysfunction was observed in one patient (2.4%). Non-survivors had a higher rate of sepsis and renal failure, compared to the survivors (p<0.05). Conclusion: The CentriMag system provides an effective temporary mechanical circulatory support for cardiac failure. The ease of implantation and high rate of successful device weaning encourage the use of CentriMag system as a temporary ventricle support.
Description
Rabus, Murat Bulent/0000-0002-4952-8637; salihi, salih/0000-0002-4477-9605
Keywords
Cardiogenic shock, end-stage heart failure, ventricular assist device
Turkish CoHE Thesis Center URL
Fields of Science
Citation
2
WoS Q
Q4
Scopus Q
Q4
Source
Volume
25
Issue
4
Start Page
543
End Page
549